Companies: 10,795·Total market cap: $144.5T
InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO.CNCNQHealthcare● Active
$3.40
$-0.20(-5.56%)
Market Cap$15295818
P/E Ratio
52W High$21
52W Low$3.01
Overview

InnoCan Pharma Corporation (INNO.CN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · INNO.CN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.33inno.cn eps ttm · inno.cn earnings per shareEarnings history
PE Ratio (TTM)inno.cn pe ratio ttm · inno.cn price to earningsPE Ratio deep dive
Revenue (TTM)$25.2Minno.cn revenue ttm · inno.cn annual revenueFull revenue history
Dividend YieldNo Dividenddoes inno.cn pay dividends · inno.cn dividend yieldDividend history
Shares Outstanding4.5Minno.cn shares outstanding · inno.cn floatShares outstanding history
Next EarningsTBAinno.cn earnings date · inno.cn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$26.6M▼ 9.60% YoY
202320242025
innocan pharma corporation revenue · inno.cn revenue 2025
FY 2025Net Income-$1.1M▲ +38.71% YoY
202320242025
innocan pharma corporation net income · inno.cn profit 2025
FY 2025EPS$-0.25▲ +40.48% YoY
202320242025
inno.cn eps · innocan pharma corporation earnings per share 2025
TTM:Revenue: $25.2MNet Income: -$1.5MEPS: $-0.33View income statement →

Stock Performance

Full History
1D-5.56%
1W+0.00%
1M-42.08%
3M-42.37%
YTD-49.25%
1Y-69.23%
5Y-89.54%

About InnoCan Pharma Corporation

CEOIris Bincovich
IPO DateSep 25, 2019
Employees11
CountryCA

InnoCan Pharma Corporation a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United Stat…

what is innocan pharma corporation · inno.cn stock overview · innocan pharma corporation company profile · who is innocan pharma corporation ceo · inno.cn CNQ · innocan pharma corporation headquarters · innocan pharma corporation business segments

About Stock Overview & Key Data

InnoCan Pharma Corporation (INNO.CN) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on CNQ since Sep 25, 2019. As of the latest trading session, INNO.CN stock price is $3.40, with a market capitalization of $15.3M. The stock has returned -69.23% over the past 12 months and -49.25% year-to-date.

In fiscal year 2025, InnoCan Pharma Corporation reported revenue of $26.6M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, InnoCan Pharma Corporation (INNO.CN) stock price is $3.40. The stock is traded on CNQ under the ticker symbol INNO.CN. The 52-week range is $3.01 – $21.00.

INNO.CN stock priceINNO.CN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice